Sleep Intervention Protocols for AuDHD Adults

Companion note to Poor Sleep and AuDHD-HFE Interactions, which establishes why sleep is a central hub in Anthony's case. This note compiles the evidence for specific interventions, with PMIDs, key findings, and evidence ratings.

Evidence Rating Key

• A = Systematic review/meta-analysis or multiple high-quality RCTs
• B = Single well-designed RCT or multiple controlled studies
• C = Pilot study, open-label trial, or strong observational evidence
• D = Expert opinion, case series, or extrapolation from adjacent populations

flowchart TD
    subgraph P1["Phase 1 - Foundation - Weeks 1-2"]
        HYGIENE["Sleep Hygiene"]
        SENSORY["Sensory Environment"]
        WAKE["Fixed Wake Time"]
    end

    GATE1{"ISI Score + Sleep Diary"}

    subgraph P2["Phase 2 - Chronobiology - Weeks 2-4"]
        MEL["Melatonin - IR + PR"]
        CHRONO["Chronotherapy"]
        MG["Magnesium - Evening"]
    end

    GATE2{"DLMO Shift + Sleep Latency"}

    subgraph P3["Phase 3 - Behavioural - Weeks 4-8"]
        ACT["Adapted CBT-I or ACT-i"]
        LIGHT["Morning Bright Light"]
    end

    GATE3{"ISI + Actigraphy + Function"}

    subgraph P4["Phase 4 - Medication Timing - Week 8+"]
        ELVANSE["Elvanse Timing Shift"]
        REVIEW["Prescriber Review"]
    end

    HYGIENE --> SENSORY --> WAKE
    WAKE --> GATE1
    GATE1 -->|"Still impaired"| MEL
    MEL --> CHRONO --> MG
    MG --> GATE2
    GATE2 -->|"Still impaired"| ACT
    ACT --> LIGHT
    LIGHT --> GATE3
    GATE3 -->|"Still impaired"| ELVANSE
    ELVANSE --> REVIEW

    classDef phase fill:#85c1e9,stroke:#2471a3,color:#0a1929
    classDef gate fill:#d5dbdb,stroke:#7f8c8d,color:#1a1a1a

    class HYGIENE,SENSORY,WAKE,MEL,CHRONO,MG,ACT,LIGHT,ELVANSE,REVIEW phase
    class GATE1,GATE2,GATE3 gate

1. Melatonin

1.1 Dosing and Formulation

Immediate-Release (IR) vs Prolonged-Release (PR)

Melatonin in ASD/ADHD — Key Trials

Melatonin in ADHD Adults with DSPS — Direct Evidence

1.2 Practical Recommendations for Anthony

• Circadian shifting: IR melatonin 0.5 mg, timed 3h before current dim-light melatonin onset (likely ~20:30-21:00 given AuDHD evening chronotype)
• Sleep-onset and maintenance: PR melatonin 2 mg at bedtime, titrate to 5 mg if needed
• Can combine both: low-dose IR for circadian shift + PR for sleep maintenance (per Palagini et al.)
• No tolerance seen in up to 2-year follow-up studies
• Iron interaction note: melatonin has antioxidant properties and may offer some ferroptosis protection — a secondary benefit given HFE status (see Ferroptosis and Neuronal Iron)

2. CBT-I Adapted for Neurodivergent Adults

2.1 Why Standard CBT-I May Fail in AuDHD

Standard CBT-I relies on:

• Sleep restriction — difficult when ADHD executive dysfunction prevents schedule adherence
• Stimulus control (leave bed if awake >20 min) — problematic for autistic adults with transition difficulties and sensory need for familiar environment
• Cognitive restructuring — may miss the point when insomnia is driven by sensory overload or circadian biology rather than maladaptive cognitions
• Homework compliance — executive function demands are high

2.2 Evidence for Adapted Approaches

2.3 Key Adaptations for AuDHD CBT-I

Based on the above evidence:

1. Replace rigid sleep restriction with gradual sleep window compression — less executive demand
2. Use ACT-based approaches (acceptance, defusion) instead of pure cognitive restructuring — suits autistic thinking styles
3. Combine with chronotherapy (light, melatonin, fixed wake time) — targets the ADHD circadian biology
4. Build in external structure (alarms, apps, visual schedules) — accommodates ADHD executive dysfunction
5. Address sensory environment explicitly — not a standard CBT-I component but essential for autism
6. Internet-delivered formats may suit autistic adults who prefer reduced social demand

3. Chronotherapy

3.1 Evidence for Morning Bright Light + Fixed Wake Times in ADHD

3.2 Practical Protocol for Anthony

Based on the van Andel trial results:

1. Low-dose melatonin (0.5 mg) timed 3h before current DLMO, advancing weekly by 1h
2. Morning bright light (10,000 lux, 30 min) — but must be paired with behavioral structure
3. Fixed wake time 7 days/week — the single most important anchor
4. Critical insight: the clock can advance without behaviour following — needs external structure (alarm, accountability, morning routine reward)
5. Consider a dawn simulator as lower-demand alternative to light box for the autism sensory profile

4. Sensory Environment Interventions

4.1 Weighted Blankets

4.2 Sensory Processing and Sleep in Autism

4.3 Practical Sensory Protocol for Anthony

Based on the evidence and the autism sensory profile:

• Weighted blanket (8-12 kg): strong evidence for insomnia in psychiatric populations including ADHD; the deep pressure input addresses proprioceptive seeking common in autism
• Complete blackout: eliminate all light sources (particularly blue/green wavelengths) — addresses visual hyper-reactivity
• Consistent sound masking (white/pink noise or brown noise): blocks auditory triggers; no specific ASD RCT but mechanistic rationale is strong given auditory hyper-reactivity
• Temperature control: cool room (16-18°C) — sensory overheating is a common autistic sleep disruptor
• Consistent tactile environment: same bedding texture, avoid changes — supports routine and reduces sensory surprises

5. Stimulant Timing Optimisation (Elvanse / Lisdexamfetamine)

5.1 Available Evidence

5.2 Practical Implications for Anthony

At Elvanse 70 mg (highest standard dose):

• Pharmacokinetic duration: 13-14 hours of active d-amphetamine
• If taken at 08:00 → active until ~21:00-22:00
• If taken at 07:00 → active until ~20:00-21:00
• Every 1 hour earlier = 1 hour less evening stimulant exposure

Recommendations:

1. Take Elvanse as early as feasible — ideally 06:30-07:00 with breakfast
2. This is challenging with ADHD delayed sleep phase — creates a conflict between "take meds early" and "wake up early"
3. Resolve by anchoring wake time first (chronotherapy) then shifting meds earlier
4. If sleep remains problematic, discuss with prescriber: some clinicians use earlier dosing + low-dose IR short-acting top-up at midday rather than one large long-acting dose
5. Monitor: if earlier dosing reduces afternoon/evening coverage, this may affect TTM control (see Trichotillomania and Neurodevelopmental Links)

Note: There is no published RCT directly testing "earlier vs later Elvanse dosing" on sleep outcomes. Evidence is extrapolated from pharmacokinetics and expert consensus. This is a significant evidence gap.

6. Magnesium for Sleep

6.1 General Sleep Evidence

6.2 Magnesium in ADHD/Autism Context

6.3 Practical Recommendations for Anthony

• Best evidence forms for sleep: Mg-L-threonate (brain bioavailability, RCT evidence) or Mg bisglycinate (RCT evidence, good tolerability)
• Dose: 200-400 mg elemental magnesium, taken in the evening
• Rationale beyond sleep: Mg is a cofactor for >300 enzymes including those involved in GABA synthesis, neurotransmitter regulation, and inflammatory modulation — all relevant to AuDHD
• Iron interaction note: Mg and iron compete for absorption; take Mg supplements at a different time of day from any iron-containing foods/supplements
• Evidence gap: no published RCT of magnesium for sleep specifically in ADHD or autism adults — current evidence is extrapolated from general population RCTs and ADHD symptom studies
• HFE relevance: Mg deficiency increases oxidative stress; repletion may offer secondary antioxidant benefit (see Copper-Zinc-Iron Interactions)

7. Integrated Protocol Summary

Based on the totality of evidence reviewed, a staged intervention protocol:

Phase 1 — Immediate (Week 1-2)

Phase 2 — Add Melatonin (Week 2-4)

Phase 3 — Add Light Therapy (Week 4-6)

Phase 4 — Behavioural (Week 6+)

8. Evidence Gaps and Watch List

• No RCT of melatonin specifically in AuDHD adults — adult evidence is from ADHD+DSPS (van Andel) or extrapolated from paediatric ASD trials
• No RCT of Elvanse timing on sleep — pharmacokinetic reasoning only
• No RCT of magnesium for sleep in ADHD/ASD — extrapolated from general population
• i-Sleep Autism trial (PMID: 39357740) — internet CBT-I co-designed with autistic adults, results pending
• White noise/sound masking in autism — mechanistic rationale strong but no sleep-focused RCT identified
• Iron status and melatonin synthesis: tryptophan hydroxylase is iron-dependent; iron overload could theoretically alter endogenous melatonin production — unstudied intersection relevant to HFE (see Iron and Circadian Rhythm, Tryptophan-Kynurenine Pathway)

Cross-References

• Poor Sleep and AuDHD-HFE Interactions
• Iron and Circadian Rhythm
• Elvanse and Mineral Metabolism
• Ferroptosis and Neuronal Iron
• Tryptophan-Kynurenine Pathway
• Trichotillomania and Neurodevelopmental Links
• Iron-Dopamine-ADHD Axis
• Late-Diagnosed Autism - Distinct Profile
• ADHD-PI and Internal Hyperactivity
• Copper-Zinc-Iron Interactions
• Diet and Supplement Strategy
• Fatigue and Burnout
• Health Research MOC